SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4i1p'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HRK_A_CHDA1501_0 (FERROCHELATASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.34A	1hrkA-4i1pA: 3.0	1hrkA-4i1pA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HRK_B_CHDB2501_0 (FERROCHELATASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.43A	1hrkB-4i1pA: 2.9	1hrkB-4i1pA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HWI_C_115C4_1 (HMG-COA REDUCTASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 7	ARG A 576 VAL A 575 ASP A 403 LYS A 341	None	1.37A	1hwiC-4i1pA: undetectable	1hwiC-4i1pA: 20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HWI_D_115D3_2 (HMG-COA REDUCTASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 7	ARG A 576 VAL A 575 ASP A 403 LYS A 341	None	1.37A	1hwiD-4i1pA: undetectable	1hwiD-4i1pA: 20.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BFP_D_H4BD1290_1 (PTERIDINE REDUCTASE 1)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 8	ARG A 392 PHE A 424 ASP A 471 TYR A 417	ACT A 804 ( 2.9A) None None None	0.99A	2bfpD-4i1pA: undetectable	2bfpD-4i1pA: 21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2C12_C_SPMC1434_1 (NITROALKANE OXIDASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	VAL A 380 ALA A 345 LEU A 346 LEU A 369 VAL A 366	None	1.19A	2c12C-4i1pA: undetectable	2c12C-4i1pA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2C12_F_SPMF1433_1 (NITROALKANE OXIDASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 11	LEU A 346 VAL A 442 LEU A 446 MET A 449 LEU A 410	None	1.29A	2c12F-4i1pA: undetectable	2c12F-4i1pA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HRC_A_CHDA701_0 (FERROCHELATASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.35A	2hrcA-4i1pA: undetectable	2hrcA-4i1pA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HRC_B_CHDB1605_0 (FERROCHELATASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 ILE A 550 VAL A 380 VAL A 458	None	1.18A	2hrcB-4i1pA: 2.1	2hrcB-4i1pA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PNJ_B_CHDB501_0 (FERROCHELATASE, MITOCHONDRIAL)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.46A	2pnjB-4i1pA: 2.3	2pnjB-4i1pA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PO5_A_CHDA501_0 (FERROCHELATASE, MITOCHONDRIAL)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.47A	2po5A-4i1pA: 2.4	2po5A-4i1pA: 22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PO5_B_CHDB501_0 (FERROCHELATASE, MITOCHONDRIAL)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 11	LEU A 515 PHE A 511 LEU A 369 VAL A 380 VAL A 458	None	1.08A	2po5B-4i1pA: 2.2	2po5B-4i1pA: 22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PO7_A_CHDA501_0 (FERROCHELATASE, MITOCHONDRIAL)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.42A	2po7A-4i1pA: 2.1	2po7A-4i1pA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PO7_B_CHDB501_0 (FERROCHELATASE, MITOCHONDRIAL)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380	None	1.15A	2po7B-4i1pA: undetectable	2po7B-4i1pA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q6F_C_010C6_0 (INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE N-[(5-METHYLISOXAZOL -3-YL)CARBONYL]ALANY L-L-VALYL-N~1~-((1R, 2Z)-4-(BENZYLOXY)-4- OXO-1-{[(3R)-2-OXOPY RROLIDIN-3-YL]METHYL }BUT-2-ENYL)-L-LEUCI NAMIDE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	3 / 3	ASN A 350 LEU A 359 HIS A 415	None	0.76A	2q6fB-4i1pA: undetectable	2q6fB-4i1pA: 22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD4_A_CHDA801_0 (FERROCHELATASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 LEU A 369 VAL A 380 VAL A 458	None	0.85A	2qd4A-4i1pA: 2.3	2qd4A-4i1pA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD4_B_CHDB928_0 (FERROCHELATASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 PHE A 511 LEU A 369 VAL A 380 VAL A 458	None	0.87A	2qd4B-4i1pA: 2.2	2qd4B-4i1pA: 21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XZ5_A_ACHA1211_0 (SOLUBLE ACETYLCHOLINE RECEPTOR)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 7	TYR A 690 SER A 689 GLN A 703 ILE A 618	None	1.20A	2xz5A-4i1pA: undetectable 2xz5B-4i1pA: undetectable	2xz5A-4i1pA: 20.35 2xz5B-4i1pA: 20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XZ5_E_ACHE1211_0 (SOLUBLE ACETYLCHOLINE RECEPTOR)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 7	GLN A 703 ILE A 618 TYR A 690 CYH A 628	None	1.38A	2xz5D-4i1pA: undetectable 2xz5E-4i1pA: undetectable	2xz5D-4i1pA: 20.35 2xz5E-4i1pA: 20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AQI_A_CHDA1_0 (FERROCHELATASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 11	LEU A 515 PHE A 511 ILE A 550 VAL A 380 VAL A 458	None	1.23A	3aqiA-4i1pA: 2.4	3aqiA-4i1pA: 22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AQI_B_CHDB6_0 (FERROCHELATASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.39A	3aqiB-4i1pA: undetectable	3aqiB-4i1pA: 22.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CS8_A_BRLA503_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	GLY A 708 ILE A 614 LEU A 602 LEU A 639 LEU A 675	None	1.36A	3cs8A-4i1pA: undetectable	3cs8A-4i1pA: 23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQ7_B_DX2B271_1 (PTERIDINE REDUCTASE 1)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 8	ARG A 392 PHE A 424 ASP A 471 TYR A 417	ACT A 804 ( 2.9A) None None None	1.02A	3jq7B-4i1pA: 4.3	3jq7B-4i1pA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQA_A_DX4A270_0 (PTERIDINE REDUCTASE 1)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 6	ARG A 392 PHE A 424 ASP A 471 TYR A 417	ACT A 804 ( 2.9A) None None None	1.01A	3jqaA-4i1pA: 3.4	3jqaA-4i1pA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQA_B_DX4B270_0 (PTERIDINE REDUCTASE 1)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 6	ARG A 392 PHE A 424 ASP A 471 TYR A 417	ACT A 804 ( 2.9A) None None None	1.01A	3jqaB-4i1pA: 5.2	3jqaB-4i1pA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQA_C_DX4C270_0 (PTERIDINE REDUCTASE 1)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 6	ARG A 392 PHE A 424 ASP A 471 TYR A 417	ACT A 804 ( 2.9A) None None None	0.98A	3jqaC-4i1pA: 5.6	3jqaC-4i1pA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JQA_D_DX4D270_0 (PTERIDINE REDUCTASE 1)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 6	ARG A 392 PHE A 424 ASP A 471 TYR A 417	ACT A 804 ( 2.9A) None None None	0.96A	3jqaD-4i1pA: 5.4	3jqaD-4i1pA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JW5_B_TOPB208_1 (DIHYDROFOLATE REDUCTASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 10	ALA A 345 LEU A 369 LEU A 460 VAL A 458 LEU A 528	None	1.18A	3jw5B-4i1pA: 2.0	3jw5B-4i1pA: 17.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDV_A_AICA375_1 (BETA-PEPTIDYL AMINOPEPTIDASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 11	GLY A 408 ARG A 374 LEU A 346 LEU A 401 LEU A 402	None	1.32A	3ndvA-4i1pA: undetectable 3ndvB-4i1pA: undetectable	3ndvA-4i1pA: 22.32 3ndvB-4i1pA: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDV_C_AICC375_1 (BETA-PEPTIDYL AMINOPEPTIDASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 11	GLY A 408 ARG A 374 LEU A 346 LEU A 401 LEU A 402	None	1.35A	3ndvC-4i1pA: undetectable 3ndvD-4i1pA: undetectable	3ndvC-4i1pA: 22.32 3ndvD-4i1pA: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDV_D_AICD374_1 (BETA-PEPTIDYL AMINOPEPTIDASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 11	LEU A 401 LEU A 402 GLY A 408 ARG A 374 LEU A 346	None	1.32A	3ndvC-4i1pA: undetectable 3ndvD-4i1pA: undetectable	3ndvC-4i1pA: 22.32 3ndvD-4i1pA: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3T3C_A_017A201_2 (HIV-1 PROTEASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 10	VAL A 632 ILE A 614 GLY A 603 ALA A 630 VAL A 686	None	1.04A	3t3cB-4i1pA: undetectable	3t3cB-4i1pA: 14.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W1W_A_CHDA1502_0 (FERROCHELATASE, MITOCHONDRIAL)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.40A	3w1wA-4i1pA: undetectable	3w1wA-4i1pA: 20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W1W_B_CHDB504_0 (FERROCHELATASE, MITOCHONDRIAL)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	6 / 12	LEU A 515 PHE A 511 LEU A 369 ILE A 550 VAL A 380 VAL A 458	None	1.41A	3w1wB-4i1pA: 2.7	3w1wB-4i1pA: 20.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4I1R_A_LZUA801_1 (MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	7 / 12	VAL A 344 LEU A 346 LYS A 379 VAL A 381 ALA A 394 GLU A 397 PHE A 398	None	0.64A	4i1rA-4i1pA: 44.1	4i1rA-4i1pA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4I1R_A_LZUA801_1 (MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	8 / 12	VAL A 344 LEU A 346 VAL A 381 ALA A 394 GLU A 397 PHE A 398 LEU A 400 LEU A 401	None	0.78A	4i1rA-4i1pA: 44.1	4i1rA-4i1pA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Y8W_C_STRC603_1 (CYTOCHROME P450 21-HYDROXYLASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	LEU A 515 VAL A 487 ILE A 550 ILE A 525 LEU A 369	None	0.96A	4y8wC-4i1pA: undetectable	4y8wC-4i1pA: 23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KI6_A_IPHA901_0 (PROTEIN ARGONAUTE-2)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 5	LEU A 409 TYR A 407 LYS A 343 LEU A 560	None	1.34A	5ki6A-4i1pA: 3.3	5ki6A-4i1pA: 19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ND3_B_TA1B601_1 (TUBULIN BETA-2B CHAIN)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	5 / 12	GLU A 500 LEU A 372 LEU A 515 THR A 370 PRO A 362	None	1.20A	5nd3B-4i1pA: undetectable	5nd3B-4i1pA: 19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WEA_A_IPHA901_0 (PROTEIN ARGONAUTE-2)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 5	LEU A 409 TYR A 407 LYS A 343 LEU A 560	None	1.22A	5weaA-4i1pA: 3.0	5weaA-4i1pA: 19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EKZ_A_SNPA414_0 (AROMATIC PEROXYGENASE)	4i1p	MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1 (Homo sapiens)	4 / 5	PHE A 459 VAL A 381 MET A 449 VAL A 442	None	1.43A	6ekzA-4i1pA: undetectable	6ekzA-4i1pA: 11.42

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1HRK_A_CHDA1501_0","FERROCHELATASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.34A","1hrkA-4i1pA:3.0","1hrkA-4i1pA:21.23"],["1HRK_B_CHDB2501_0","FERROCHELATASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.43A","1hrkB-4i1pA:2.9","1hrkB-4i1pA:21.23"],["1HWI_C_115C4_1","HMG-COA REDUCTASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 576;VAL A 575;ASP A 403;LYS A 341","None","1.37A","1hwiC-4i1pA:undetectable","1hwiC-4i1pA:20.46"],["1HWI_D_115D3_2","HMG-COA REDUCTASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 576;VAL A 575;ASP A 403;LYS A 341","None","1.37A","1hwiD-4i1pA:undetectable","1hwiD-4i1pA:20.46"],["2BFP_D_H4BD1290_1","PTERIDINE REDUCTASE 1","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 392;PHE A 424;ASP A 471;TYR A 417","ACT A 804 ( 2.9A);None;None;None","0.99A","2bfpD-4i1pA:undetectable","2bfpD-4i1pA:21.11"],["2C12_C_SPMC1434_1","NITROALKANE OXIDASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"VAL A 380;ALA A 345;LEU A 346;LEU A 369;VAL A 366","None","1.19A","2c12C-4i1pA:undetectable","2c12C-4i1pA:21.34"],["2C12_F_SPMF1433_1","NITROALKANE OXIDASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 346;VAL A 442;LEU A 446;MET A 449;LEU A 410","None","1.29A","2c12F-4i1pA:undetectable","2c12F-4i1pA:21.34"],["2HRC_A_CHDA701_0","FERROCHELATASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.35A","2hrcA-4i1pA:undetectable","2hrcA-4i1pA:21.23"],["2HRC_B_CHDB1605_0","FERROCHELATASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;ILE A 550;VAL A 380;VAL A 458","None","1.18A","2hrcB-4i1pA:2.1","2hrcB-4i1pA:21.23"],["2PNJ_B_CHDB501_0","FERROCHELATASE, MITOCHONDRIAL","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.46A","2pnjB-4i1pA:2.3","2pnjB-4i1pA:21.23"],["2PO5_A_CHDA501_0","FERROCHELATASE, MITOCHONDRIAL","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.47A","2po5A-4i1pA:2.4","2po5A-4i1pA:22.17"],["2PO5_B_CHDB501_0","FERROCHELATASE, MITOCHONDRIAL","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;LEU A 369;VAL A 380;VAL A 458","None","1.08A","2po5B-4i1pA:2.2","2po5B-4i1pA:22.17"],["2PO7_A_CHDA501_0","FERROCHELATASE, MITOCHONDRIAL","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.42A","2po7A-4i1pA:2.1","2po7A-4i1pA:21.23"],["2PO7_B_CHDB501_0","FERROCHELATASE, MITOCHONDRIAL","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380","None","1.15A","2po7B-4i1pA:undetectable","2po7B-4i1pA:21.23"],["2Q6F_C_010C6_0","INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE;N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",3,"ASN A 350;LEU A 359;HIS A 415","None","0.76A","2q6fB-4i1pA:undetectable","2q6fB-4i1pA:22.28"],["2QD4_A_CHDA801_0","FERROCHELATASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;LEU A 369;VAL A 380;VAL A 458","None","0.85A","2qd4A-4i1pA:2.3","2qd4A-4i1pA:21.23"],["2QD4_B_CHDB928_0","FERROCHELATASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;LEU A 369;VAL A 380;VAL A 458","None","0.87A","2qd4B-4i1pA:2.2","2qd4B-4i1pA:21.23"],["2XZ5_A_ACHA1211_0","SOLUBLE ACETYLCHOLINE RECEPTOR","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"TYR A 690;SER A 689;GLN A 703;ILE A 618","None","1.20A","2xz5A-4i1pA:undetectable;2xz5B-4i1pA:undetectable","2xz5A-4i1pA:20.35;2xz5B-4i1pA:20.35"],["2XZ5_E_ACHE1211_0","SOLUBLE ACETYLCHOLINE RECEPTOR","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"GLN A 703;ILE A 618;TYR A 690;CYH A 628","None","1.38A","2xz5D-4i1pA:undetectable;2xz5E-4i1pA:undetectable","2xz5D-4i1pA:20.35;2xz5E-4i1pA:20.35"],["3AQI_A_CHDA1_0","FERROCHELATASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;PHE A 511;ILE A 550;VAL A 380;VAL A 458","None","1.23A","3aqiA-4i1pA:2.4","3aqiA-4i1pA:22.17"],["3AQI_B_CHDB6_0","FERROCHELATASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.39A","3aqiB-4i1pA:undetectable","3aqiB-4i1pA:22.17"],["3CS8_A_BRLA503_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"GLY A 708;ILE A 614;LEU A 602;LEU A 639;LEU A 675","None","1.36A","3cs8A-4i1pA:undetectable","3cs8A-4i1pA:23.20"],["3JQ7_B_DX2B271_1","PTERIDINE REDUCTASE 1","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 392;PHE A 424;ASP A 471;TYR A 417","ACT A 804 ( 2.9A);None;None;None","1.02A","3jq7B-4i1pA:4.3","3jq7B-4i1pA:19.38"],["3JQA_A_DX4A270_0","PTERIDINE REDUCTASE 1","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 392;PHE A 424;ASP A 471;TYR A 417","ACT A 804 ( 2.9A);None;None;None","1.01A","3jqaA-4i1pA:3.4","3jqaA-4i1pA:19.38"],["3JQA_B_DX4B270_0","PTERIDINE REDUCTASE 1","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 392;PHE A 424;ASP A 471;TYR A 417","ACT A 804 ( 2.9A);None;None;None","1.01A","3jqaB-4i1pA:5.2","3jqaB-4i1pA:19.38"],["3JQA_C_DX4C270_0","PTERIDINE REDUCTASE 1","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 392;PHE A 424;ASP A 471;TYR A 417","ACT A 804 ( 2.9A);None;None;None","0.98A","3jqaC-4i1pA:5.6","3jqaC-4i1pA:19.38"],["3JQA_D_DX4D270_0","PTERIDINE REDUCTASE 1","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"ARG A 392;PHE A 424;ASP A 471;TYR A 417","ACT A 804 ( 2.9A);None;None;None","0.96A","3jqaD-4i1pA:5.4","3jqaD-4i1pA:19.38"],["3JW5_B_TOPB208_1","DIHYDROFOLATE REDUCTASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"ALA A 345;LEU A 369;LEU A 460;VAL A 458;LEU A 528","None","1.18A","3jw5B-4i1pA:2.0","3jw5B-4i1pA:17.17"],["3NDV_A_AICA375_1","BETA-PEPTIDYL AMINOPEPTIDASE;BETA-PEPTIDYL AMINOPEPTIDASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"GLY A 408;ARG A 374;LEU A 346;LEU A 401;LEU A 402","None","1.32A","3ndvA-4i1pA:undetectable;3ndvB-4i1pA:undetectable","3ndvA-4i1pA:22.32;3ndvB-4i1pA:22.32"],["3NDV_C_AICC375_1","BETA-PEPTIDYL AMINOPEPTIDASE;BETA-PEPTIDYL AMINOPEPTIDASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"GLY A 408;ARG A 374;LEU A 346;LEU A 401;LEU A 402","None","1.35A","3ndvC-4i1pA:undetectable;3ndvD-4i1pA:undetectable","3ndvC-4i1pA:22.32;3ndvD-4i1pA:22.32"],["3NDV_D_AICD374_1","BETA-PEPTIDYL AMINOPEPTIDASE;BETA-PEPTIDYL AMINOPEPTIDASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 401;LEU A 402;GLY A 408;ARG A 374;LEU A 346","None","1.32A","3ndvC-4i1pA:undetectable;3ndvD-4i1pA:undetectable","3ndvC-4i1pA:22.32;3ndvD-4i1pA:22.32"],["3T3C_A_017A201_2","HIV-1 PROTEASE;HIV-1 PROTEASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"VAL A 632;ILE A 614;GLY A 603;ALA A 630;VAL A 686","None","1.04A","3t3cB-4i1pA:undetectable","3t3cB-4i1pA:14.36"],["3W1W_A_CHDA1502_0","FERROCHELATASE, MITOCHONDRIAL","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.40A","3w1wA-4i1pA:undetectable","3w1wA-4i1pA:20.98"],["3W1W_B_CHDB504_0","FERROCHELATASE, MITOCHONDRIAL","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",6,"LEU A 515;PHE A 511;LEU A 369;ILE A 550;VAL A 380;VAL A 458","None","1.41A","3w1wB-4i1pA:2.7","3w1wB-4i1pA:20.98"],["4I1R_A_LZUA801_1","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",7,"VAL A 344;LEU A 346;LYS A 379;VAL A 381;ALA A 394;GLU A 397;PHE A 398","None","0.64A","4i1rA-4i1pA:44.1","4i1rA-4i1pA:100.00"],["4I1R_A_LZUA801_1","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",8,"VAL A 344;LEU A 346;VAL A 381;ALA A 394;GLU A 397;PHE A 398;LEU A 400;LEU A 401","None","0.78A","4i1rA-4i1pA:44.1","4i1rA-4i1pA:100.00"],["4Y8W_C_STRC603_1","CYTOCHROME P450 21-HYDROXYLASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"LEU A 515;VAL A 487;ILE A 550;ILE A 525;LEU A 369","None","0.96A","4y8wC-4i1pA:undetectable","4y8wC-4i1pA:23.11"],["5KI6_A_IPHA901_0","PROTEIN ARGONAUTE-2","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"LEU A 409;TYR A 407;LYS A 343;LEU A 560","None","1.34A","5ki6A-4i1pA:3.3","5ki6A-4i1pA:19.34"],["5ND3_B_TA1B601_1","TUBULIN BETA-2B CHAIN","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",5,"GLU A 500;LEU A 372;LEU A 515;THR A 370;PRO A 362","None","1.20A","5nd3B-4i1pA:undetectable","5nd3B-4i1pA:19.38"],["5WEA_A_IPHA901_0","PROTEIN ARGONAUTE-2","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"LEU A 409;TYR A 407;LYS A 343;LEU A 560","None","1.22A","5weaA-4i1pA:3.0","5weaA-4i1pA:19.79"],["6EKZ_A_SNPA414_0","AROMATIC PEROXYGENASE","4i1p","MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA TRANSLOCATION PROTEIN 1","Homo sapiens",4,"PHE A 459;VAL A 381;MET A 449;VAL A 442","None","1.43A","6ekzA-4i1pA:undetectable","6ekzA-4i1pA:11.42"]]